T. Rowe Price Investment Management
CLDX icon

T. Rowe Price Investment Management’s Celldex Therapeutics CLDX Stock Holding History

T. Rowe Price Investment Management’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,697,498
Closed -$42.9M – 662
2024
Q4 		$42.9M Sell
1,697,498
-37,024
-2% -$936K 0.03% 429
2024
Q3 		$59M Buy
+1,734,522
New +$59M 0.04% 378